The development of B cells is a highly regulated process that includes the generation of B cell antigen receptors (BCRs; [@bib38]). The enormous variability observed in BCRs largely results from recombination of *Ig* heavy chain (HC; *IgH*) and light chain (LC; *IgL*) gene loci ([@bib42]). During B cell development, the first recombination events take place at the HC gene locus leading to expression of a μ-class HC (μHC) in pre--B cells. Together with the surrogate LC (SLC), composed of λ5 and VpreB, µHC associates with the signal transduction subunits Ig-α and Ig-β to form a pre-BCR. As a result of auto--cross-linking, the pre-BCR shows a distinctive capacity for autonomous signaling required for normal pre--B cell development ([@bib50]). The pre--B cell stage is characterized by several pre-BCR--induced rounds of cell division and subsequent recombination at the *IgL* gene locus, which leads to surface expression of a BCR and progression to the early immature B cell stage ([@bib16]).

*Ig* gene recombination requires the action of recombination-activating gene products Rag-1 and -2 ([@bib40]). To achieve correct and sequential recombination, Rag expression must be tightly regulated. The activity of phosphoinositide-3-kinase (PI3K; [@bib40]; [@bib31]), which is largely orchestrated by cytokines, as well as pre-BCR and BCR signaling in B-lymphocytes, has been described to play an important role in negatively regulating *Ig* gene rearrangement by inhibiting Rag transcription ([@bib1]; [@bib9]). PI3K generates phosphatidylinositol-3,4,5-trisphosphate, a lipid second messenger that facilitates membrane recruitment and activation of numerous proteins, of which protein kinase B (PKB, also known as Akt; [@bib36]) plays a central role in PI3K-mediated negative regulation of *Ig* gene recombination. For instance, SLP-65 (SH2 domain-containing lymphocyte protein of 65 kD, also called BLNK or BASH), a central adaptor protein acting downstream of pre-BCR and BCR, was shown to promote *IgL* gene recombination by down-regulating PKB activity ([@bib15]). Moreover, these studies demonstrated the importance of FoxO transcription factors in the process of *Ig* gene recombination. FoxO proteins are the mammalian counterparts of *Caenorhabditis elegans* decay-accelerating factor 16 and share an evolutionarily conserved DNA-binding domain ([@bib7]). They are negatively regulated by PKB-mediated phosphorylation, which results in their export from the nucleus and proteasomal degradation ([@bib3]; [@bib26]; [@bib45]). The activity of PKB is negatively regulated by phosphatase and tensin homolog (Pten; [@bib30]), whose main substrate is phosphatidylinositol-3,4,5-trisphosphate generated by PI3K. The role of Pten in B cells has been studied by analyzing floxed Pten mice crossed to mice expressing Cre-recombinase from the B cell--specific CD19 promoter. The resulting animals displayed hyperproliferation of B cells and defects in class switch recombination ([@bib44]; [@bib37]).

*Ig* gene recombination requires the action of the Kruppel-like zinc finger transcription factor Ikaros ([@bib6]), which is involved in activating Rag expression and the accessibility of the *IgH* gene locus ([@bib39]). Hence, disruption of Ikaros leads to an early blockade in lymphocyte development and complete absence of the earliest B cell progenitors in mice ([@bib13]; [@bib52]; [@bib33]). Another crucial factor for *IgH* gene recombination is the B-lineage commitment factor Pax5 ([@bib5]), whose absence leads to a halt at the pro--B cell stage with cells retaining a broad potential to develop into lymphoid and myeloid lineages ([@bib51]). Pax5 acts as a transcriptional regulator and has been demonstrated to activate the transcription of genes involved in pre-BCR and BCR signaling such as CD19, Ig-α, and SLP-65 ([@bib35]; [@bib41]). In addition to transcriptional regulation of signaling proteins, it is also involved in V~H~-DJ~H~ gene recombination. Interestingly, Pax5 appears to be mainly required for the recombination of distal V~H~ gene segments. Proximal V~H~ segments are efficiently recombined in the absence of Pax5 ([@bib12]; [@bib23]). This suggests that other factors initiate proximal V~H~-DJ~H~ recombination before Pax5 action ([@bib53]; [@bib32]; [@bib46]; [@bib22]; [@bib18]). It has been shown that the transcription factors Pax5, early B cell factor 1 (EBF1), FoxO1, and Ikaros play major roles during *Ig* gene rearrangement and are thus essential for early B cell development ([@bib14]; [@bib38]; [@bib12]; [@bib1]; [@bib39]). However, it remained ill defined whether they play redundant roles or whether they are specifically involved in particular steps of early B cell development. Here, we show that the function of FoxO1 in *Ig* gene recombination is largely mediated by Ikaros, whose transcripts show an unusual splicing pattern in the absence of FoxO1. We show that proper splicing of Ikaros transcripts and *Ig* gene recombination can be achieved by Pten expression, nuclear FoxO1, or inhibition of PI3K activity.

RESULTS
=======

Pten mediates μHC recombination in pro--B cells
-----------------------------------------------

To study the role of FoxO1 in B cell development, we first generated conditional FoxO1-deficient mice by crossing mb1-Cre mice ([@bib19]) to FoxO1^fl/fl^ mice ([@bib48]). As described before ([@bib9]), the resulting animals displayed a severe block in B cell development (unpublished data). We were unable to establish IL-7--dependent in vitro cultures of FoxO1-deficient B cell precursors from FoxO1^fl/fl^/mb1-Cre mice. Because FoxO1 activity is largely dependent on Pten, we reasoned that Pten-deficient mice ([@bib44]) might be a suitable source for B cell progenitors that would allow us to study FoxO1 function. Thus, we crossed mb1-Cre mice to Pten^fl/fl^ mice to generate conditional Pten-deficient mice (Pten^fl/fl^/mb1-Cre), in which Pten is inactivated at an early stage of B cell development. We analyzed BM cells from Pten^fl/fl^/mb1-Cre mice by flow cytometry and found that B cell development was blocked at the pro--B cell stage ([Fig. 1 A](#fig1){ref-type="fig"} and not depicted). Comparison of BM cells from conditional Pten-deficient mice with those of conditional FoxO1-deficient mice revealed a nearly identical block in B cell development (unpublished data). We isolated BM cells from different Pten^fl/fl^/mb1-Cre mice and cultured them in medium complemented with IL-7. From these slowly growing and fragile cultures we obtained two independent cell lines (\#10 and \#71) that had deleted Pten (Pten^−/−^). The results presented in this study were obtained using \#71 and were reproducibly repeated with \#10. Flow cytometric analysis revealed that these Pten^−/−^ cells lacked μHC expression and were trapped in the pro--B cell stage of development ([Fig. 1 B](#fig1){ref-type="fig"} and not depicted). To test whether reconstitution of Pten expression induces μHC expression, we retrovirally transduced the Pten^−/−^ pro--B cells with either an empty vector (EV) or a Pten expression vector and analyzed μHC expression by flow cytometry. We found that the amount of retrovirally expressed Pten was comparable to endogenous Pten in WT pro--B cells and that only Pten-reconstituted cells were positive for μHC ([Fig. 1, B and C](#fig1){ref-type="fig"}).

![**Pten-deficient pro--B cells do not express µHC.** (A) Flow cytometric analysis of BM cells from Pten^fl/fl^ mice and Pten^fl/fl^/mb1-Cre mice (*n* \> 3 per genotype), stained for the indicated surface markers. Numbers in quadrants indicate percentages of cells. (B) Flow cytometric analysis of µHC expression in Pten-deficient pro--B cells reconstituted with either an empty expression vector (EV) or with a Pten expression vector (black lines) as compared with untransduced cells (filled gray). (C) Immunoblot analysis of Pten expression in Pten-deficient pro--B cells transduced with an empty expression vector (EV) or with a Pten expression vector as compared with WT cells. Immunoblot of actin served as a loading control. (D) Southern blot analysis of PCR fragments amplified with specific primers for V~H~DQ52, V~H~7183, V~H~J558, and J~H~4 from genomic DNA of Pten-deficient cells transduced with an empty expression vector (EV) or with a Pten expression vector. Wedges above lines indicate 2× serial dilutions. PCR for the splicing factor SRP20 was used as control. Purified CD43^−^ splenic B cells from WT mice served as a control. (E) Immunoblot analysis of FoxO1 expression in Pten-deficient cells transduced with either an empty expression vector (EV) or a Pten expression vector as compared with WT cells. Immunoblot of actin served as a loading control. (F) Immunoblot analysis of FoxO1 and µHC expression in Pten-deficient cells transduced with either an empty expression vector (EV), a FoxO1 expression vector, or an expression vector encoding activated FoxO1 (FoxO1-A3). Immunoblot of actin served as a loading control. (G) Immunoblot analysis of Pten-deficient cells transduced with EV or FoxO1-A3 and analyzed for FoxO1 expression as compared with WT cells. Actin was used as a loading control. Data are representative of at least two to three independent experiments.](JEM_20110216R_Fig1){#fig1}

To test whether the inability of the Pten^−/−^ pro--B cells to express μHC was a result of defective *IgH* gene recombination, we analyzed two independent Pten-deficient cell lines for the recombination status of the *IgH* genes. This analysis showed that Pten^−/−^ cells had completed D to J~H~1 gene rearrangement, whereas V~H~ to DJ~H~ gene recombination was not detectable neither for proximal V~H~7183 nor distal V~H~J558 genes ([Fig. 1 D](#fig1){ref-type="fig"}).

Upon reconstitution with Pten, we detected V~H~ to DJ~H~ rearrangement in Pten^−/−^ cells; however, it was restricted to the proximal V~H~7183 gene family, as we did not observe any recombination of the distal J558 family of V~H~ segments after reconstitution with Pten ([Fig. 1 D](#fig1){ref-type="fig"}). Interestingly, only V~H~7183 to DJ~H~4 gene rearrangements were detected, which might suggest that secondary DJ~H~ recombination had occurred, thereby deleting the DJ~H~1 recombination observed in the parental Pten^−/−^ cells ([Fig. 1 D](#fig1){ref-type="fig"}). Sequencing of the respective band revealed that the detected V~H~7183 to DJ~H~4 recombination was clonal. This suggests that the rearrangement of proximal V~H~ elements was inefficient and that a cell with a productive V~H~ to DJ~H~ recombination has a strong selective advantage induced by pre-BCR expression (unpublished data).

Next, we analyzed FoxO1 expression in Pten^−/−^ pro--B cells and found that they had reduced FoxO1 expression as compared with WT cells and that FoxO1 amounts were increased upon reconstitution of Pten expression ([Fig. 1 E](#fig1){ref-type="fig"}). To test whether induction of FoxO1 is involved in *Ig* gene rearrangement, we expressed WT FoxO1 or a constitutively nuclear form of FoxO1 (FoxO1-A3; [@bib4]) in Pten^−/−^ cells and analyzed μHC expression. Retroviral transduction of WT FoxO1 resulted in only a minor increase of total FoxO1 protein amounts and no induction of μHC expression. In contrast, transduction of FoxO1-A3 increased FoxO1 protein amounts and induced μHC expression in Pten^−/−^ pro--B cells ([Fig. 1 F](#fig1){ref-type="fig"}). Importantly, expression levels of FoxO1-A3 were comparable to FoxO1 protein amounts in WT cells ([Fig. 1 G](#fig1){ref-type="fig"}). Together, the data suggest that activation of FoxO1 is the main Pten-dependent step for *IgH* gene rearrangement.

Ikaros restores *IgH* gene recombination in Pten^−/−^ cells
-----------------------------------------------------------

Our data are in agreement with available results, suggesting an important role of FoxO1 during the process of *Ig* gene recombination. However, it remained unclear whether the ubiquitously expressed FoxO1 exerts its actions directly or via additional proteins that promote *IgH* gene rearrangement. Therefore, we screened for lymphocyte-specific factors that might act downstream of FoxO1.

Pax5 is an essential transcription factor for B cell development and *IgH* gene recombination ([@bib14]; [@bib38]; [@bib12]; [@bib1]; [@bib39]). It has been shown that Pax5 binds to regulatory elements in the *IgH* gene locus to promote distal V~H~ to DJ~H~ gene recombination by chromatin remodeling ([@bib35]; [@bib17]; [@bib12]; [@bib23]). Indeed, immunoblot analysis showed that Pax5 expression was reduced in Pten^−/−^ pro--B cells as compared with WT cells ([Fig. 2 B](#fig2){ref-type="fig"}). Thus, we tested whether expression of Pax5 in Pten^−/−^ cells may lead to restoration of μHC expression. However, retroviral transduction of Pten^−/−^ pro--B cells with a Pax5 expression vector substantially increased Pax5 protein levels but did not induce any μHC expression ([Fig. 2, A and B](#fig2){ref-type="fig"}). Together, these data suggest that although low levels of Pax5 are sufficient for normal CD19 expression in Pten^−/−^ cells (unpublished data), Pax5 is not sufficient to induce V~H~DJ~H~ recombination in the absence of Pten even after retroviral transduction to increase Pax5 expression. Similar to Pax5, EBF1 was not able to induce μHC expression in Pten^−/−^ pro--B cells ([Fig. 2, A and C](#fig2){ref-type="fig"}).

![**FoxO1 and Ikaros restore µHC expression in Pten-deficient pro--B cells.** (A) Flow cytometric analysis of µHC expression in Pten-deficient pro--B cells transduced with either an empty expression vector (EV) or expression vectors for FoxO1-A3, Ebf1, Pax5, or Ikaros (black lines) as compared with untransduced cells (filled gray). (B) Immunoblot analysis of Pax5, Ikaros, and µHC expression in freshly isolated CD19^+^ cells from Pten^fl/fl^/mb1-Cre, and WT mice, and Pten-deficient pro--B cells transduced with either an empty expression vector (EV) or with an expression vector encoding Pax5. Immunoblotting for actin served as a loading control. (C) Immunoblot analysis of Pten-deficient cells transduced with either EV or EBF1 and WT cells for expression of EBF1. Actin served as a loading control. (D) Immunoblot analysis for Ikaros expression in Pten-deficient cells transduced with EV or Ikaros and in WT cells. Immunoblotting for tubulin served as a loading control. (E) RT-PCR analysis of Rag1 and Rag2 mRNA in Pten-deficient cells, WT cells, and Pten-deficient cells transduced with expression vectors encoding Ikaros, Pten, or FoxO1-A3. HPRT served as a loading control. (F) GFP expression after recombination of an artificial reporter system in WT cells, Pten-deficient cells, and in a recombination-defective cell line (Rag2^−/−^). As shown on the top, Rag-1/2 activity leads to the recombination of the two RSS (black triangles) flanking the inverted GFP cDNA, resulting in GFP expression. Data are representative of at least three independent experiments.](JEM_20110216R_Fig2){#fig2}

The Kruppel-like zinc finger transcription factor Ikaros has been implicated in *IgH* gene recombination ([@bib39]) and was shown to bind to regulatory elements in the *Ig* HC locus ([@bib39]; [@bib43]). Furthermore, we found that Pten^−/−^ pro--B cells lacked endogenous Ikaros protein ([Fig. 2 B](#fig2){ref-type="fig"}). Therefore, we analyzed whether Ikaros expression could restore the defect in *Ig* gene recombination observed in Pten^−/−^ pro--B cells. Indeed, we found that retroviral expression of Ikaros to levels comparable to WT cells led to μHC expression in Pten^−/−^ cells ([Fig. 2, A and D](#fig2){ref-type="fig"}).

Because Ikaros was shown to induce the expression of Rag1/2 ([@bib39]; [@bib43]), we tested whether Pten^−/−^ pro--B cells lacked Rag1/2 expression and were therefore unable to show *Ig* gene recombination after Pax5 expression. Our experiments show that Rag1/2 expression is slightly reduced in Pten^−/−^ pro--B cells as compared with WT pro--B cells and that introducing Ikaros, Pten, or FoxO1-A3 induces Rag1/2 expression ([Fig. 2 E](#fig2){ref-type="fig"}). However, the Pten^−/−^ pro--B cells were capable of recombining an artificial recombination substrate to a similar extent as WT cells ([Fig. 2 F](#fig2){ref-type="fig"}). It seems therefore unlikely that the reduced Rag1/2 expression levels account for the inability of Pax5 to induce any *IgH* gene recombination in Pten^−/−^ pro--B cells.

Pax5 requires Ikaros for activating distal V~H~ segments
--------------------------------------------------------

To investigate why Pax5 was unable to induce μHC expression in Pten^−/−^ cells, we analyzed the recombination status of the *IgH* genes. This analysis showed that retrovirally expressed Pax5 failed to induce any V~H~ to DJ~H~ rearrangement in Pten^−/−^ pro--B cells ([Fig. 3 A](#fig3){ref-type="fig"}). In contrast, similar to Pten, expression of Ikaros resulted in efficient recombination of only proximal (V~H~7183) but not distal (V~H~J558) gene segments ([Fig. 3, A and B](#fig3){ref-type="fig"}). Pax5 has been described to be important for the recombination of distal V~H~ segments ([@bib17]; [@bib12]; [@bib23]). The inability of Pten-reconstituted Pten^−/−^ pro--B cells to induce any distal V~H~DJ~H~ recombination might be explained by the reduced Pax5 expression in Pten^−/−^ cells. Therefore, we tested Pax5 expression upon Pten reconstitution and found that Pax5 levels were even further reduced ([Fig. 3 C](#fig3){ref-type="fig"}). We then tested whether coexpression of Pax5 with either Pten or Ikaros would result in distal V~H~ to DJ~H~ rearrangements. Indeed, Pten-deficient cells recombined distal V~H~J558 segments when Pax5 was coexpressed with either Pten or Ikaros ([Fig. 3, D and E](#fig3){ref-type="fig"}). In addition, different recombinations of proximal V~H~7183 segments were detected as determined by usage of different J~H~ segments, indicating that the increased efficiency is not limited to distal V~H~ gene segments ([Fig. 3 E](#fig3){ref-type="fig"}).

![**Pax5 requires Ikaros for the recombination of distal V~H~ gene segments.** (A) Southern blot analysis of PCR fragments amplified from genomic DNA of Pten-deficient cells reconstituted with expression vectors encoding Pax5 or Pten, with specific primers for V~H~7183, V~H~J558, and J~H~4. Wedges above lines indicate 2× serial dilutions. PCR for the splicing factor SRP20 was used as a loading control. Purified CD43^−^ splenic B cells from WT mice served as a control. (B) Southern blot analysis of PCR fragments amplified from genomic DNA of Pten-deficient cells transduced with an Ikaros expression vector, with specific primers for V~H~7183 and J~H~4, and V~H~J558 and J~H~4. Purified CD43^−^ splenic B cells from WT mice served as a control. (C) Immunoblot analysis of Pten-deficient cells transduced either with EV or Pten and analyzed for Pten and Pax5 expression. Actin was used as a loading control. (D) Southern blot analysis of PCR fragments amplified from genomic DNA of Pten-deficient cells transduced with the indicated combinations of expression vectors, with specific primers for V~H~J558 and J~H~4. Wedges above lines indicate 2× serial dilutions. PCR for the splicing factor SRP20 was used as loading control. Purified CD43^−^ splenic B cells from WT mice served as a control. (E) PCR analysis of genomic DNA of Pten-deficient cells transduced with the indicated expression vectors. Primers were specific for V~H~7183 and J~H~4. The splicing factor SRP20 was used as a control. (F) RT-PCR analysis of *Igh* germline transcripts in Pten-deficient cells transduced with the indicated combinations of expression vectors with specific primers for V~H~7183 and V~H~J558. HPRT served as loading control. Data are representative of at least two to three independent experiments.](JEM_20110216_Fig3){#fig3}

Because gene activation is a prerequisite for *Ig* gene rearrangement, we analyzed germline transcripts of proximal and distal V~H~ genes as direct signs of gene activation and accessibility of the respective segments for the recombination machinery. These experiments clearly show that Ikaros is sufficient to activate proximal V~H~7183, but not distal V~H~J558 transcripts. For induction of V~H~J558 germline transcripts Pax5 is an obligate factor ([Fig. 3 F](#fig3){ref-type="fig"}). These results suggest that, although required, Pax5 is not sufficient for the activation of distal V~H~ gene recombination and is strictly dependent on Ikaros for this function.

Pten/FoxO1 are essential for Ikaros expression
----------------------------------------------

The facts that Ikaros was not expressed in Pten^−/−^ cells and that we observed similar effects on *IgH* gene rearrangement when we expressed Pten, FoxO1-A3, or Ikaros prompted us to test whether Pten may induce Ikaros expression by activation of FoxO1. Indeed, immunoblot analysis showed that introduction of Pten up-regulates Ikaros expression in Pten^−/−^ pro--B cells ([Fig. 4 A](#fig4){ref-type="fig"}). Moreover, the constitutively nuclear form of FoxO1 (FoxO1-A3) resulted in a strong induction of Ikaros expression, whereas WT FoxO1 was unable to induce Ikaros expression in the absence of Pten ([Fig. 4 B](#fig4){ref-type="fig"}, lanes 4 and 5). To exclude that Ikaros deficiency can only be observed after cultivating Pten^−/−^ cells in vitro, we tested Ikaros expression in freshly isolated BM B cells from Pten^fl/fl^/mb1-Cre mice. Immunoblot analysis showed that BM B cells from these mice lacked Ikaros expression and were similar to the in vitro--cultured pro--B cells ([Fig. 4 C](#fig4){ref-type="fig"}). These data, and the fact that Ikaros expression in Pten-deficient cells induced µHC expression without altering FoxO1 protein amounts ([Fig. 4 B](#fig4){ref-type="fig"}, lane 3), suggest that Ikaros acts downstream of FoxO1 in promoting *IgH* gene recombination. Induction of Ikaros by FoxO1 implies that expression of a dominant-negative version of Ikaros should reverse the effects of FoxO1-A3 on *IgH* gene recombination. Thus, we coexpressed FoxO1-A3 together with IK6, a dominant-negative splice variant of Ikaros ([@bib25]; [@bib21]; [@bib39]). Interestingly, IK6 efficiently abolished µHC expression mediated by FoxO1-A3 ([Fig. 4 D](#fig4){ref-type="fig"}). These data suggest that induction of Ikaros activity is key for FoxO1-mediated *IgH* gene rearrangement.

![**Ikaros expression and function is essential for μHC expression.** (A) Immunoblot analysis for Pten and Ikaros expression in Pten-deficient cells transduced with an EV or with a Pten expression vector. Immunoblotting for actin served as loading control. (B) Immunoblot analysis of Ikaros and FoxO1 expression in Pten-deficient cells transduced with the indicated expression vectors. Immunoblotting for actin served as loading control. (C) Immunoblot analysis of FoxO1, Ikaros, and Pten expression in freshly isolated CD19^+^ BM cells from Pten-sufficient and Pten-deficient mice. Immunoblotting for actin served as loading control. (D) Flow cytometric analysis of Pten-deficient cells transduced with expression vectors encoding FoxO1-A3 and dominant-negative Ikaros (IK6). Single- (R1 and R2) and double-positive cells (R3) were gated and are displayed as histograms (right) showing µHC expression. Numbers indicate the percentages of cells expressing μHC. Data are representative of at least two to three independent experiments.](JEM_20110216R_Fig4){#fig4}

PI3K signaling represses Ikaros expression
------------------------------------------

Because increased FoxO1 expression was required for induction of Ikaros and because the FoxO transcription factors are negatively regulated by PKB-mediated phosphorylation, we tested whether inhibition of PI3K signaling would induce Ikaros and result in μHC expression in Pten^−/−^ cells. We therefore treated Pten^−/−^ cells with the PI3K inhibitor LY294002 and performed immunoblot and FACS analysis to test for μHC expression. The results show a strong increase of FoxO1 and induction of Ikaros expression upon treatment of Pten-deficient cells with LY294002 ([Fig. 5 A](#fig5){ref-type="fig"}). Moreover, μHC was readily observed after 48 h of treatment with the PI3K inhibitor LY294002 ([Fig. 5, A and B](#fig5){ref-type="fig"}). The expression of μHC was also restored by inhibiting PKB/Akt (unpublished data). To test whether the induction of μHC expression by LY294002 treatment was mediated by Ikaros, we compared μHC expression in LY294002-treated cells that were transduced either with an empty control vector or with dominant negative IK6. Our results show that the positive effect of LY294002 treatment on μHC expression was reversed when dominant-negative IK6 was expressed in Pten^−/−^ pro--B cells ([Fig. 5 C](#fig5){ref-type="fig"}). Collectively, these results identify Ikaros as a crucial element downstream of Pten and FoxO1 in PI3K-mediated negative regulation of *IgH* gene rearrangement.

![**Inhibition of PI3K leads to expression of Ikaros and to μHC generation.** (A) Immunoblot analysis of FoxO1, Ikaros, and μHC expression in Pten-deficient cells treated with either DMSO or the PI3K inhibitor LY294002. Immunoblotting for actin served as loading control. (B) Flow cytometric analysis of µHC expression in Pten-deficient cells treated with either DMSO or the PI3K inhibitor LY294002. (C) Flow cytometric analysis for µHC and GFP expression of Pten-deficient cells transduced with an EV or an expression vector encoding dominant-negative Ikaros (IK6) and treated with LY294002. (D) Immunoblot analysis for Ikaros expression in SLP-65--deficient pre--B cells treated with DMSO or the PI3K inhibitor LY294002. Immunoblotting for actin served as loading control. (E) Immunoblot analysis for Ikaros expression in SLP-65--deficient pre--B cells transduced with 4-hydroxytamoxifen (4-OHT)--inducible forms of either SLP-65 (ER^T2^-SLP65) or FoxO1-A3 (ER^T2^-FoxO1-A3). Upon sorting of positively transduced cells, the cells were treated with the solvent ethanol (−) or 4-OHT (+) to activate ER^T2^-SLP65 and ER^T2^-FoxO1-A3. Immunoblotting for actin served as loading control. (F) Top, FACS plots for κLC expression in SLP-65--deficient pre--B cells transduced with an EV or with an Ikaros expression vector. Cells were cultured in the presence of IL-7. Bottom, dot plots for κLC expression in SLP-65--deficient pre--B cells transduced with an EV or with an expression vector for DN-Ikaros (IK6); both were treated with the PI3K inhibitor LY294002. Numbers in quadrants indicate percentages of cells in the respective region. Data are representative of at least two to three independent experiments.](JEM_20110216_Fig5){#fig5}

To investigate whether Ikaros also acts downstream of FoxO1 in *IgL* gene recombination, we used our SLP-65 reconstitution system for the induction of κLC expression. Our previous results suggested that SLP-65 interferes with PI3K signaling to activate FoxO proteins and induce *IgL* gene recombination ([@bib15]). This predicts that induction of SLP-65 should lead to induction of Ikaros expression. Indeed, we found that induction of Ikaros expression in SLP-65--deficient pre--B cells can be achieved by LY294002 treatment, by activation of SLP-65, or by activation of FoxO1-A3 ([Fig. 5, D and E](#fig5){ref-type="fig"}). To show that Ikaros is involved in LC expression in SLP-65--deficient pre--B cells, we expressed Ikaros in these cells and found that this was sufficient to induce κLC expression. Moreover, combining LY294002 treatment with the inhibition of Ikaros activity by IK6 completely blocked κLC expression in SLP-65--deficient pre--B cells ([Fig. 5 F](#fig5){ref-type="fig"}). This suggests that Ikaros acts downstream of SLP-65 and FoxO1 for the induction of *IgL* gene rearrangement.

Aberrant Ikaros splicing in Pten^−/−^ pro--B cells
--------------------------------------------------

To investigate the underlying mechanism of FoxO1-mediated activation of Ikaros, we analyzed Ikaros transcripts in Pten^−/−^ pro--B cells before and after expression of Pten or Foxo1-3A. RT-PCR analysis for the Ikaros 5′-region showed normal amounts of Ikaros transcripts in Pten^−/−^ pro--B cells. RT-PCR analysis for full-length Ikaros, however, showed that Pten^−/−^ pro--B cells lacked normal full-length transcripts and revealed the existence of aberrant Ikaros transcripts in these cells ([Fig. 6 A](#fig6){ref-type="fig"} and not depicted). Sequence analyses showed that the aberrant transcript lacked exons 5 and 6 and contained a 378-nucleotide insertion in exon 7, which was obviously derived from the preceding intron and introduced a stop codon at the beginning of the transactivation domain encoded by exon 7 ([Fig. 6 B](#fig6){ref-type="fig"} and [Fig. S1](http://www.jem.org/cgi/content/full/jem.20110216/DC1){#supp1}). The underlying mechanism for generating this aberrant Ikaros transcript is unclear because there are no conventional splice sites and no obvious homology to known nonconventional splicing pathways ([@bib54]). To confirm the presence of the aberrant Ikaros transcript in Pten^−/−^ pro--B cells, we designed specific primers for this transcript and used them for RT-PCR analyses ([Fig. 6 B](#fig6){ref-type="fig"}). This analysis confirmed that the aberrant Ikaros transcript is expressed in Pten^−/−^ pro--B cells and that it was completely abolished after expression of Pten or FoxO1-A3 in these cells ([Fig. 6 C](#fig6){ref-type="fig"}). To test whether aberrant Ikaros splicing was induced by PI3K signaling, we treated Pten^−/−^ pro--B cells with LY294002 and found that normal Ikaros splicing is restored after inhibition of PI3K ([Fig. 6 D](#fig6){ref-type="fig"}). Thus, our results show that PI3K regulates Ikaros expression at the level of RNA processing by activation of a yet unknown splicing pathway. To confirm that this novel abnormal splicing of Ikaros is regulated by FoxO1 and can also be observed in other cells, we used BM-derived pro--B cells from FoxO1^fl/fl^ mice and introduced a tamoxifen-inducible Cre-recombinase by retroviral transduction. Cre activation led to deletion of the floxed *FoxO1* gene and abolished FoxO1 expression resulting in a severe reduction of Ikaros protein amounts ([Fig. 6 E](#fig6){ref-type="fig"} and not depicted), which confirms the essential role of FoxO1 for Ikaros expression. Furthermore, RT-PCR analyses showed that, similar to Pten^−/−^ pro--B cells, deletion of *FoxO1* leads to abnormal Ikaros transcripts ([Fig. 6 F](#fig6){ref-type="fig"}). These data show that aberrant Ikaros transcripts are not restricted to the Pten^−/−^ pro--B cells and that FoxO1 is required for normal Ikaros splicing and expression. By down-regulating the amounts of FoxO1, PI3K activates aberrant splicing of Ikaros, thereby inhibiting the generation of normal transcripts and Ikaros protein expression.

![**Aberrant Ikaros splicing in the absence of Pten.** (A) RT-PCR analysis of Ikaros transcripts in Pten-deficient cells, WT cells, and Pten-deficient cells transduced with expression vectors for Pten or FoxO1-A3, using gene-specific primers. The forward primer is located in exon 2 (E2f), the reverse primers either in exon 4 (E4r) or in exon 7 (E7r) of the Ikaros transcript. HPRT was used as a loading control. (B) Schematic view of Ikaros transcripts and pre-mRNA splicing in the presence and absence of Pten. Arrows specify the location of the indicated primers. Forward primers were located in exons 2 (E2f), 4 (E4f), and 7 (E7f). Reverse primers were located in exons 4 (E4r), 7 (E7r), and the inserted sequence from intron 6 (Inr). (C) RT-PCR analysis of Ikaros transcripts in cells from A. The forward primer is located in exon 7 (E7f) and the reverse primer is located in the inserted intron fragment (Inr). HPRT was used as a control. (D) RT-PCR analysis of Ikaros transcripts in Pten-deficient cells and Pten-deficient cells treated with LY294002 as compared with WT cells. Forward primers were either located in exon 2 (E2f) or exon 4 (E4f), the reverse primers were located either in exon 7 (E7r) or in the inserted intron fragment (Inr). HPRT was used as a loading control. (E) Immunoblot analysis of FoxO1 and Ikaros expression in BM-derived cells from FoxO1^fl/fl^ mice transduced with a tamoxifen-inducible Cre-recombinase (Cre-ER^T2^) before and after deletion of FoxO1 by 4-OHT treatment. Treatment with the solvent EtOH and cells transduced with an expression vector encoding ER^T2^ were used as controls. Immunoblotting for actin served as loading control. (F) RT-PCR analysis of Ikaros transcripts in Pten-deficient cells and Cre-ER^T2^--transduced FoxO1^fl/fl^ cells with or without 4-OHT treatment. Forward primers were either located in exon 2 (E2f) or in exon 7 (E7f), the reverse primers were either located in exon 7 (E7r) or in the inserted intron fragment (Inr). HPRT was used as a loading control. Data are representative of two to three independent experiments.](JEM_20110216R_Fig6){#fig6}

DISCUSSION
==========

This study establishes the transcription factor Ikaros as a novel component of the PI3K-regulated signaling machinery in developing B cells. Furthermore, our study shows that the activation of Ikaros is a central event during the induction of *Ig* gene rearrangement by FoxO1. In fact, the dominant-negative Ikaros version IK6 blocked FoxO1-mediated *Ig* gene recombination in our experiments. Interestingly, Ikaros and FoxO1 were both shown to directly bind and activate Rag1/2 genes ([@bib28]; [@bib1]; [@bib9]; [@bib39]; [@bib43]). However, our results show that residual Rag1/2 expression is present in Ikaros-deficient cells, which is sufficient for recombining an artificial VDJ recombination substrate. Moreover, the induction of Ikaros expression required an increase in FoxO1 activity, which was achieved by either reconstituting Pten expression or by introducing a constitutively nuclear FoxO1 form (FoxO1-A3). The basal FoxO1 expression, which is observed in Pten-deficient pro--B cells, seems to be important for the survival of the cells and might be responsible for the Rag expression that was detected in these cells. Surprisingly, the observed Rag expression together with Pax5 was not sufficient to induce any V~H~-DJ~H~ recombination in our cells unless Ikaros activity was available either by retroviral transduction of Ikaros expression constructs or by activation of endogenous Ikaros expression through Pten. However, the ability of Pten^−/−^ cells to recombine an artificial substrate demonstrated that the recombination machinery is expressed and, in principle, functional in Pten^−/−^ pro--B cells. This suggests that V~H~ gene segments cannot be recombined when only Pax5 is expressed in these cells.

Interestingly, retroviral expression of Pten or Ikaros in Pten-deficient pro--B cells did not completely restore VDJ recombination either, as only usage of proximal VH7183 segments could be detected. Furthermore, the clonal nature of cells carrying these rearrangements suggests that the recombination process is rather inefficient. One reason for this might be the reduction of Pax5 expression in these cells. In addition, although the recombination machinery is expressed in these cells, the Rag proteins might be inefficiently recruited to V~H~ gene segments.

Although Pax5 has been described to be the central factor for the activation and recombination of distal V~H~ gene segments ([@bib17]; [@bib12]; [@bib23]), our results clearly show that Pax5 requires the cooperation of Ikaros for this function. Thus, Pax5 alone is essential but not sufficient for the recombination of distal V~H~ gene segments. In addition to its role in the recombination of distal V~H~ segments, Pax5 seems to also be involved in the recombination of proximal V~H~ segments, as our data show additional proximal V~H~ to DJ~H~ recombinations when Pax5 was coexpressed with Ikaros.

Assuming that Ikaros increases the general accessibility of V~H~ gene segments ([@bib39]), it is unclear how it cooperates with Pax5 to increase the accessibility of distal V~H~ gene segments. It is possible that Ikaros induces chromatin modifications on both proximal and distal V~H~ gene segments and that these modifications are sufficient for proximal V~H~ gene usage but not for distal V~H~ segments. Such modifications might then facilitate the recruitment of Pax5, which introduces additional modifications that lead to changes in chromatin architecture and subsequent rearrangement of distal V~H~ genes ([@bib22]; [@bib18]). Together, the emerging scheme suggests that the recombination of different V~H~ gene segments is regulated by networks of transcription factors that operate in hierarchical (FoxO1/Ikaros) and cooperative (Pax5/Ikaros) manners. This divergent regulation of Pax5 and Ikaros may provide a mechanism for the fine-tuned regulation of V~H~ gene segment activation, which might explain the observed differential usage of V~H~ gene segments during B cell development. For instance, fetal liver B cells display a clear bias toward proximal V~H~ segments, such as V~H~81X, a member of the V~H~7183 family ([@bib53]; [@bib32]). Interestingly, also during early B cell development in the BM, V~H~ usage is biased toward proximal gene segments, whereas they are underrepresented in peripheral B cells ([@bib53]; [@bib20]; [@bib8]; [@bib32]; [@bib46]).

After successful *IgH* gene rearrangement and pre-BCR expression, FoxO expression is induced by SLP-65--mediated down-regulation of PKB ([@bib15]) at the end of the pre--B cell stage. At this stage, FoxO proteins induce *IgL* gene recombination and, as in the case for *IgH* gene rearrangement, our data suggest that Ikaros acts downstream of FoxO1 to allow *IgL* gene rearrangement. The role of Ikaros in *IgL* gene recombination is supported by several observations. First, Ikaros has been shown to bind to the κLC gene locus ([@bib28]). Second, the Ikaros family member Aiolos was shown to directly down-regulate the expression of the SLC component λ5, thereby effecting pre-BCR down-regulation, which is required for the induction of *IgL* gene recombination ([@bib47]). Third, Ikaros expression is induced by pre-BCR signaling and is required for the cell cycle arrest at the end of the pre--B cell stage ([@bib49]), where Ikaros has been reported to repress c-Myc and to induce p27 expression. These are important steps for the activation of *IgL* recombination because c-Myc activity interferes with κLC gene recombination, whereas induction of p27 results in cell cycle arrest and stabilization of Rag2 protein ([@bib27]; [@bib10]; [@bib29]). The ability of Ikaros to interfere with cell cycle progression is in full agreement with the tumor suppressor role of Ikaros ([@bib52]; [@bib34]; [@bib49]). Indeed, deletions within *IKZF1*, the gene encoding Ikaros, seem to be a characteristic feature of BCR/ABL1-positive acute lymphoblastic leukemia (ALL) ([@bib52]; [@bib34]; [@bib49]). Moreover, our previous results suggested that BCR/ABL1 induces aberrant Ikaros splicing and the generation of the dominant-negative IK6 form ([@bib52]; [@bib34]; [@bib49]). This inactivation of Ikaros function is important for BCR/ABL1-mediated transformation, as Ikaros induces cell cycle arrest of BCR/ABL1-transformed ALL cells ([@bib49]).

Interestingly, the aberrant nonconventional splicing identified in the present study has not been described previously and does not seem to encode any Ikaros protein isoforms, as antibodies directed against the N terminus of Ikaros failed to detect any Ikaros isoforms in Pten^−/−^ pro--B cells. Although we cannot exclude the presence of such isoforms, they are unlikely to act in a dominant-negative manner because expression of WT Ikaros was sufficient to induce efficient *IgH* gene recombination. An urgent question is how intron sequences can be inserted into exon 7 of Ikaros to disrupt the open reading frame. The fact that we observed this insertion in independent cell lines, in primary cells, and under different conditions suggests that this is a physiological PI3K-activated process, which differs from conventional alternative splicing. It is conceivable that this PI3K-activated nonconventional splicing pathway may regulate the expression of further genes, thereby providing a reversible mechanism for switching off genes at the level of RNA processing by inserting intron sequences into mature transcripts to disrupt their open reading frame. The emerging scheme suggests that PI3K signaling induces proliferation and blocks differentiation (as *Ig* gene rearrangement) by interfering with conventional splicing of tumor suppressors such as Ikaros and that FoxO1 exerts its tumor suppressor function partially by restoring the conventional splicing machinery to allow the expression of downstream targets.

MATERIALS AND METHODS
=====================

### Mice.

Pten^fl/fl^ mice (provided by T. Mak, Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, Toronto, ON, Canada) and FoxO1^fl/fl^ mice (provided by R.A. DePinho, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA) were bred to mb1-Cre (CD79a-Cre) transgenic mice to achieve B cell--specific Cre-mediated recombination in early pro--B cells. Mice used for peripheral B cell analysis and BM cultures were 6--8 wk old.

Mice were bred and housed in the animal facility of the Max-Planck-Institute of Immunobiology and Epigenetics. All animal experiments were done in compliance with the guidelines of the German law and were approved by the Animal Care and Use Committees of the Max-Planck-Institute of Immunobiology and Epigenetics and the local government.

### Cell culture and biochemistry.

Cells were cultured in Iscove's medium (Biochrom) containing 10% heat-inactivated FCS (Vitromex), 2 mM [l]{.smallcaps}-glutamine, 100 U/ml penicillin, 100 U/ml streptomycin (Invitrogen), and 5 × 10^−5^ M 2-mercaptoethanol. For IL-7--dependent growth, the supernatant of J558L cells stably transfected with a vector encoding mouse IL-7 was supplemented in excess. Pten-deficient cell lines were established by culturing BM cells of the respective mice for 14 d in IL-7--supplemented medium. For inhibition of PI3K, cells were treated with 30 µM LY294002 (Merck Biosciences) or as control with DMSO (Fluka Analytical) for the indicated times.

### Plasmids and retroviral transduction.

To generate Pten-IRES-GFP, a full-length cDNA encoding Pten was subcloned into the retroviral vector backbone pMIG. The plasmid for expression of WT FoxO1 was generated by PCR amplification of the cDNA encoding full-length FoxO1, which was subsequently ligated into the pMIG retroviral vector. To generate mutant FoxO1-A3, three point mutations were inserted by PCR (T24A, S254A, and S319A). This mutant lacks the three phosphorylation sites of Akt and is therefore not underlying the regulation by PI3K/Akt signaling. Full-length FoxO1-A3 was subcloned into the pMIG vector. The plasmid for expression of Ikaros was kindly provided by I. Ferreirós Vidal and M. Merkenschlager (Imperial College London, London, England, UK). The dominant-negative mutant of Ikaros was generated by PCR amplification of a cDNA fragment lacking exons 2--6, which encode the DNA binding site ([@bib34]), and was subcloned into the bicistronic pMIG vector. Subsequently, the GFP fragment was replaced by the CD8 sequence. pMITom-Pax5 was provided by R. Grosschedl and E. Mandel (Max-Planck-Institute for Immunobiology and Epigenetics).

Viral supernatants were generated using the Phoenix retroviral producer cell line as described in the manufacturer's instructions. In brief, Phoenix cells were cultured for 48 h in Iscove's culture medium + 10% FCS. Cells were plated at a density of 10^6^ cells per ml to generate supernatants after transfection using GeneJuice (EMD). Retroviral supernatants were harvested after 36 and 60 h. For the subsequent transduction, Pten-deficient cells were mixed with supernatants and centrifuged at 300 *g* at 37°C for 3 h. Transduced cells were returned to culture and propagated in medium containing IL-7 for 4--5 d and were analyzed by flow cytometry.

### Flow cytometry.

Cell suspensions were stained by standard procedures for flow cytometry analysis. Intracellular FACS staining was done using Fix and perm cell permeabilization kit (ADG), and then measured by FACSCalibur or LSRII flow cytometers (BD) using Cy5--anti-μHC (SouthernBiotech), FITC--anti-CD43 (SouthernBiotech), PE--anti-B220 (SouthernBiotech), Cy5--anti-CD25 (BD), PE--anti-cKIT (BD), and Alexa Fluor 647--anti-CD19 (BD).

### Immunoblotting.

For immunoblot analysis, 1.5 × 10^6^ cells/ml were collected and lysed in 50 µl of modified RIPA buffer (50 mM Tris HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, pH 8, 1 mM sodium orthovanadate, 1 mM NaF, and protease inhibitor cocktail \[Sigma-Aldrich\]). Lysates were subjected to 10% SDS-PAGE and transferred to PVDF membranes (Millipore). Membranes were blocked with 5% milk powder in PBT (PBS and 0.1% Tween-20) for 2 h at room temperature with constant agitation. Primary antibodies were diluted in PBT supplemented with 4% BSA fraction V (Enzo Life Sciences); secondary antibodies were diluted in blocking solution. Immunoreactive proteins were detected using a chemiluminescence detection system (ECL; GE Healthcare). Antibodies used were anti-Pten (Cell Signaling Technologies), anti-Ikaros (Active Motif Biotech), anti-FoxO1 (Cell Signaling Technologies), anti-Pax5 (Abcam), anti-μHC (SouthernBiotech), and anti-Actin (I-19; Santa Cruz Biotechnology, Inc.).

### PCR analysis of *IgH* gene rearrangements.

DNA recombination at the IgH locus was assessed as previously described ([@bib2]). Serial dilutions of genomic DNA were analyzed by PCR with primers specific for the V~H~J558, V~H~7183, DQ52 gene segments and a primer 3′ of J~H~4 ([@bib11]; [@bib24]), and SRP20 was used as loading control ([@bib24]). Subsequently, PCR products were separated by gel electrophoresis on a 1% agarose gel and were analyzed by Southern blotting with a 500-bp probe downstream of JH4.

### PCR analysis of Ikaros transcripts.

PCR analysis of Ikaros transcripts were performed with specific forward primers located in exon 2 (E2), exon 4 (E4), or exon 7 (E7f). The reverse primers were located in exon 4 (E4), exon 7 (E7), or in the inserted intron fragment (Inr). Primer sequences were E2f, 5′-TCGAGGCATGGCCAGTAATGT-3′; E4f, 5′-CATCTTTGCAACTATGCCTGC-3′; E7f, 5′-AGACAAGTGCCTGTCAGACAT-3′; E4r, 5′-GTCCTCAGGTGGCCGGTGAGG-3′; E7r, 5′-TGTACACCTTCAGCTGCTCG-3′; and Inr, 5′-TAGCCCTCACTGTCCTTGG-3′.

### Online supplemental material.

Fig. S1 shows a schematic overview of the Ikaros transcript in the absence of Pten and its sequence. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20110216/DC1>.
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